VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
UNH
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
UNHUnitedHealth Group Incorporated
$389.68$353.9B
Overview & Tools
OverviewChart Terminal ↗AnalysisVisualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
  1. Home
  2. Financial Ratios

  1. Home
  2. Stocks
  3. UNH
  4. Financial Ratios

UnitedHealth Group Incorporated (UNH) Financial Ratios

Latest Ratios: P/E Ratio 22.1x · EV/EBITDA 14.5x · ROE 11.8%. (1996–2025 historical series)

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly

UNH Valuation Multiples

Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Market Cap$353.9B$300.4B$469.9B$493.8B$503.7B$480.0B$337.0B$284.0B$244.9B$217.2B$154.9B
Enterprise Value$407.9B$354.4B$521.5B$535.8B$537.9B$504.7B$363.5B$313.7B$270.6B$236.9B$177.5B
P/E Ratio →22.1324.9532.6222.0625.0327.7721.8820.5220.4420.5722.07
P/S Ratio0.790.671.171.331.551.671.311.171.081.080.84
P/B Ratio3.492.954.584.995.836.284.784.574.364.173.83
P/FCF15.5018.6922.7019.2321.5224.1416.7517.3217.9418.7619.15
P/OCF17.9715.2519.4216.9919.2221.4915.2015.3815.5815.9715.82

P/E links to full P/E history page with 30-year chart

UNH EV Ratios

Enterprise-value multiples — capital-structure-neutral measures of total business value

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
EV / Revenue—0.791.301.441.661.751.411.301.201.180.96
EV / EBITDA14.4715.2014.3314.7516.9018.6414.3714.0013.6813.5711.84
EV / EBIT21.5118.9521.7516.5618.9221.0516.2315.9315.6015.5713.72
EV / FCF—22.0525.1920.8622.9825.3718.0719.1419.8220.4721.94

UNH Profitability

Margins and return-on-capital ratios measuring operating efficiency

Margins

Full margin charts and quarterly trend are on the Earnings History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Gross Margin18.5%18.5%22.3%24.5%24.6%24.2%26.1%23.8%23.8%23.4%23.5%
Operating Margin4.2%4.2%8.1%8.7%8.8%8.3%8.7%8.1%7.7%7.6%7.0%
Net Profit Margin2.7%2.7%3.6%6.0%6.2%6.0%6.0%5.7%5.3%5.2%3.8%

Return on Capital

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
ROE11.8%11.8%14.3%24.2%24.7%23.5%23.2%23.4%22.1%22.8%18.5%
ROA4.0%4.0%5.0%8.6%8.8%8.4%8.3%8.5%8.2%8.1%6.0%
ROIC9.2%9.2%16.4%18.6%19.2%18.1%17.8%17.0%16.9%16.9%16.2%
ROCE9.7%9.7%17.5%19.5%19.6%18.5%18.9%18.6%18.5%18.8%18.2%

UNH Leverage & Debt

Solvency and debt-coverage ratios — lower is generally safer

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Debt / Equity0.770.770.750.680.670.600.620.650.650.610.82
Debt / EBITDA3.363.362.111.861.811.701.721.821.851.822.20
Net Debt / Equity—0.530.500.420.400.320.380.480.460.380.56
Net Debt / EBITDA2.322.321.421.161.080.911.051.331.301.131.50
Debt / FCF—3.362.491.641.461.241.321.811.881.702.79
Interest Coverage4.674.676.149.9713.5914.4413.4711.5512.3912.8212.12

UNH Liquidity & Efficiency

Short-term solvency ratios and asset-utilisation metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Current Ratio0.790.790.830.790.770.790.740.690.730.730.69
Quick Ratio0.790.790.830.790.770.790.740.690.730.730.69
Cash Ratio0.240.240.280.300.310.310.270.230.270.310.27
Asset Turnover—1.451.341.361.321.361.301.391.491.451.51
Inventory Turnover———————————
Days Sales Outstanding———————————

UNH Shareholder Yields

Earnings, FCF, buyback, and dividend yields — total returns to shareholders

Dividends

Full dividend history and growth charts are on the Dividend History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Dividend Yield2.2%2.6%1.6%1.4%1.2%1.1%1.4%1.4%1.4%1.3%1.5%
Payout Ratio65.7%65.7%52.3%30.2%29.8%30.5%29.8%28.4%27.7%26.3%32.2%

Total Shareholder Return Metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Earnings Yield4.5%4.0%3.1%4.5%4.0%3.6%4.6%4.9%4.9%4.9%4.5%
FCF Yield6.5%5.4%4.4%5.2%4.6%4.1%6.0%5.8%5.6%5.3%5.2%
Buyback Yield1.6%1.8%1.9%1.6%1.4%1.0%1.3%1.9%1.8%0.7%0.8%
Total Shareholder Yield3.8%4.5%3.5%3.0%2.6%2.1%2.6%3.3%3.2%2.0%2.3%
Shares Outstanding—$910M$929M$938M$950M$956M$961M$966M$983M$985M$968M

Key Metrics

Growth RegimeMixed
ProfitabilityModerate
Balance SheetAdequate
Cash FlowMixed
Top Statement Risk

Medicare Advantage cost and DOJ exposure

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Combined Ratio Swings Reveal Medical Cost Sensitivity

Based on UNH's reported quarterly ratios, the combined ratio ranged from 91.7% in 2025Q1 to 99.7% in 2025Q4 before settling at 94.2% in 2026Q3, leaving underwriting margins thin and highly sensitive to medical cost timing. Investors should note that any sustained move above 100% would erase underwriting profit entirely.

The swing from 91.7% to 99.7% over three quarters is driven largely by the loss ratio, which moved between 67.3% and 83.7%, suggesting that reserve estimates and utilization trends dominate the result rather than expense discipline. The 2026Q3 recovery to 94.2% is encouraging, but the expense ratio of 13.7% against 25.6% in 2026Q2 indicates the quarterly comparison is distorted by timing, so the run-rate underwriting margin remains unclear. Analysts should strip out prior-year development before treating the most recent quarter as representative.

ROE Recovery Remains Below Earlier Peak Levels

As reported in UNH's quarterly ratio data, ROE fell from 6.1% in 2026Q1 to 3.9% in 2026Q3, below the 5.9% to 6.1% range seen in 2024 and 2025, suggesting the return profile has not yet re-established its prior level. Based on reported figures, this decline coincides with a rising loss ratio.

ROE depends on underwriting profit plus investment income on float, and with the combined ratio near 94% the underwriting contribution is modest, leaving the return heavily reliant on float yield. The ROA of 1.3% against a 2026Q1 level of 2.0% points to compressed asset-level earnings rather than a leverage effect. The data suggests the return recovery is incomplete and that investors should monitor whether margin stabilization can lift ROE back toward the mid-single-digit range.

Premium Multiple Rests on Forward Earnings Recovery

Based on UNH's reported figures, the trailing P/E of 29.79 compares with a forward P/E of 19.13, and the P/B of 3.53 sits well above the sector peers ELV at 2.14 and HUM at 2.95. The gap implies the market is pricing a substantial earnings rebound.

A premium P/B combined with an ROE of 3.9% implies that the market expects returns to recover well above current levels, as a 3.5x book multiple is difficult to justify at single-digit ROE on a sustained basis. The compression from trailing to forward P/E reflects expected earnings recovery, which depends on the combined ratio holding near or below 94%. The conglomerate premium associated with the Optum segments may be supporting the multiple, but this rests on expectations that have not yet been demonstrated in the reported return data.

Debt-to-Equity Stable but Coverage Volatile

As reported in quarterly ratio data, UNH's debt-to-equity has held in a narrow 0.69 to 0.77 band, indicating stable financial leverage, while interest coverage swung from 9.49 in 2026Q1 to 0.26 in 2025Q4. Based on reported figures, the coverage volatility appears driven by earnings rather than debt levels.

Because D/E has remained steady while coverage collapsed in 2025Q4, the variance is best read as an earnings-denominator effect rather than a rise in borrowing cost. Premium-to-surplus leverage is not provided in the supplied data, so underwriting leverage against statutory capital cannot be confirmed. Investors should treat the balance sheet as adequate but note that low coverage in weaker quarters leaves limited cushion if utilization pressure persists.

P/B Overstates Value Given Float Dependence

The most commonly misapplied metric here is the trailing P/E of 29.79, which is distorted by reserve development and EPS swings from $6.85 to $0.01 across 2025. Based on reported figures, a P/B-anchored view better reflects the invested-asset base backing reserves.

Trailing P/E is distorted by prior-year reserve adjustments and the 2025Q4 near-zero earnings, making the multiple unreliable for judging a single period. Book value, which largely consists of invested assets supporting claims reserves, is a more stable anchor, though a P/B of 3.53 still implies investors expect strong future returns. Analysts should adjust earnings for reserve development and assess the DOJ Medicare Advantage exposure before relying on any single valuation multiple.

Download Financial Ratios Data

Includes 30+ ratios · 30 years · Updated daily

Consensus & Technical Research Suite
Open UNH Terminal

UNH Chart Terminal

WASM

Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.

Launch Terminal

Live Breakouts Feed

LIVE

High-probability breakout stocks crossing their pivot across 5 pattern engines.

Explore Setups

UNH Stock Analysis

Bull/bear thesis, analyst target revisions, and earnings execution.

View Analysis

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

UNH — Frequently Asked Questions

Quick answers to the most common questions about buying UNH stock.

What is UnitedHealth Group Incorporated's P/E ratio?

UnitedHealth Group Incorporated's current P/E ratio is 22.1x. The historical average is 20.1x. This places it at the 66th percentile of its historical range.

What is UnitedHealth Group Incorporated's EV/EBITDA?

UnitedHealth Group Incorporated's current EV/EBITDA is 14.5x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 12.6x.

What is UnitedHealth Group Incorporated's ROE?

UnitedHealth Group Incorporated's return on equity (ROE) is 11.8%. The historical average is 19.6%.

Is UNH stock overvalued?

Based on historical data, UnitedHealth Group Incorporated is trading at a P/E of 22.1x. This is at the 66th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.

What is UnitedHealth Group Incorporated's dividend yield?

UnitedHealth Group Incorporated's current dividend yield is 2.23% with a payout ratio of 65.7%.

What are UnitedHealth Group Incorporated's profit margins?

UnitedHealth Group Incorporated has 18.5% gross margin and 4.2% operating margin.

How much debt does UnitedHealth Group Incorporated have?

UnitedHealth Group Incorporated's Debt/EBITDA ratio is 3.4x, indicating high leverage. A ratio between 2-4x is manageable but warrants monitoring.